Top

Published in:

01-03-2018 | Original Article

Correlations among multifocal electroretinography and optical coherence tomography findings in patients with Parkinson’s disease

Authors: Metin Unlu, Duygu Gulmez Sevim, Murat Gultekin, Cagatay Karaca

Published in: Neurological Sciences | Issue 3/2018

Abstract

To assess the correlation between functional and anatomical evaluations with multifocal electroretinography (mfERG) and spectral-domain optical coherence tomography (SD-OCT) in patients with Parkinson’s disease (PD). This cross-sectional study involved 116 eyes of 58 patients with PD and 30 age- and sex-matched control subjects. All study participants underwent a comprehensive neuro-ophthalmic examination, retinal single-layer thicknesses and volumes, and peripapillary retinal nerve fiber layer (pRNFL) measurements with SD-OCT, and the patients’ mfERG recordings were evaluated. The macular retinal nerve fiber layer (mRNFL), ganglion cell layer (GCL), inner plexiform layer (IPL), outer nuclear layer (ONL), retinal pigment epithelium (RPE), and photoreceptor layer (PR) thicknesses, and mRNFL, RPE, and PR volumes were found lower in PD compared to those of controls, while outer plexiform layer (OPL) volumes were increased (p < 0.05). We found delayed implicit times and decreased amplitudes in the mfERG of PD patients versus those in control subjects (p < 0.05). We found significant correlations between outer macular volumes, PR thicknesses, and N1 amplitudes of rings 2 and 3and P1 amplitudes of rings 3, 4, and 5. Our study revealed thinning of both inner and outer retinal single layers, increased OPL volume, and delayed implicit times and decreased amplitudes in the mfERG of PD patients versus control subjects and correlation between structural and functional parameters. Our findings point out that SD-OCT and mfERG could both serve as non-invasive tools for evaluating ophthalmic manifestations of Parkinson’s disease.

Park A, Stacy M (2009) Non-motor symptoms in Parkinson’s disease. J Neurol 256(Suppl 3):293–298. https://doi.org/10.1007/s00415-009-5240-1 CrossRefPubMed

Bodis-Wollner I (2009) Retinopathy in Parkinson disease. J Neural Transm (Vienna) 116(11):1493–1501. https://doi.org/10.1007/s00702-009-0292-z CrossRef

Price MJ, Feldman RG, Adelberg D, Kayne H (1992) Abnormalities in color vision and contrast sensitivity in Parkinson’s disease. Neurology 42(4):887–890. https://doi.org/10.1212/WNL.42.4.887 CrossRefPubMed

Demirci S, Gunes A, Koyuncuoglu HR, Tok L, Tok O (2016) Evaluation of corneal parameters in patients with Parkinson’s disease. Neurol Sci 37(8):1247–1252. https://doi.org/10.1007/s10072-016-2574-1 CrossRefPubMed

Seigo MA, Sotirchos ES, Newsome S, Babiarz A, Eckstein C, Ford ET, Oakley JD, Syc SB, Frohman TC, Ratchford JN, Balcer LJ, Frohman EM, Calabresi PA, Saidha S (2012) In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques. J Neurol 259(10):2119–2130. https://doi.org/10.1007/s00415-012-6466-x CrossRefPubMed

Garcia-Martin E, Rodriguez-Mena D, Satue M, Almarcegui C, Dolz I, Alarcia R, Seral M, Polo V, Larrosa JM, Pablo LE (2014) Electrophysiology and optical coherence tomography to evaluate Parkinson disease severity. Invest Ophthalmol Vis Sci 55(2):696–705. https://doi.org/10.1167/iovs.13-13062 CrossRefPubMed

Hood DC et al (2012) ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition). Doc Ophthalmol 124(1):1–13. https://doi.org/10.1007/s10633-011-9296-8 CrossRefPubMed

Miri S, Glazman S, Mylin L, Bodis-Wollner I (2016) A combination of retinal morphology and visual electrophysiology testing increases diagnostic yield in Parkinson’s disease. Parkinsonism Relat Disord 22(Suppl 1):S134–S137. https://doi.org/10.1016/j.parkreldis.2015.09.015 CrossRefPubMed

La Morgia C, Barboni P, Rizzo G, Carbonelli M, Savini G, Scaglione C, Capellari S, Bonazza S, Giannoccaro MP, Calandra-Buonaura G, Liguori R, Cortelli P, Martinelli P, Baruzzi A, Carelli V (2013) Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern? Eur J Neurol 20(1):198–201. https://doi.org/10.1111/j.1468-1331.2012.03701.x CrossRefPubMed

10.

Reichmann H (2010) Clinical criteria for the diagnosis of Parkinson’s disease. Neurodegener Dis 7(5):284–290. https://doi.org/10.1159/000314478 CrossRefPubMed

11.

Ramaker C, Marinus J, Stiggelbout AM, van Hilten BJ (2002) Systematic evaluation of rating scales for impairment and disability in Parkinson’s disease. Mov Disord 17(5):867–876. https://doi.org/10.1002/mds.10248 CrossRefPubMed

12.

Gonzalez-Lopez JJ et al (2014) Comparative diagnostic accuracy of ganglion cell-inner plexiform and retinal nerve fiber layer thickness measures by Cirrus and Spectralis optical coherence tomography in relapsing-remitting multiple sclerosis. Biomed Res Int 2014:128517CrossRefPubMedPubMedCentral

13.

Garcia-Martin E, Larrosa JM, Polo V, Satue M, Marques ML, Alarcia R, Seral M, Fuertes I, Otin S, Pablo LE (2014) Distribution of retinal layer atrophy in patients with Parkinson disease and association with disease severity and duration. Am J Ophthalmol 157(2):470–478 e2. https://doi.org/10.1016/j.ajo.2013.09.028 CrossRefPubMed

14.

Altintas O et al (2008) Correlation between retinal morphological and functional findings and clinical severity in Parkinson’s disease. Doc Ophthalmol 116(2):137–146. https://doi.org/10.1007/s10633-007-9091-8 CrossRefPubMed

15.

Hajee ME, March WF, Lazzaro DR, Wolintz AH, Shrier EM, Glazman S, Bodis-Wollner IG (2009) Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol 127(6):737–741. https://doi.org/10.1001/archophthalmol.2009.106 CrossRefPubMed

16.

Rohani M, Langroodi AS, Ghourchian S, Falavarjani KG, SoUdi R, Shahidi G (2013) Retinal nerve changes in patients with tremor dominant and akinetic rigid Parkinson’s disease. Neurol Sci 34(5):689–693. https://doi.org/10.1007/s10072-012-1125-7 CrossRefPubMed

17.

Albrecht P, Müller AK, Südmeyer M, Ferrea S, Ringelstein M, Cohn E, Aktas O, Dietlein T, Lappas A, Foerster A, Hartung HP, Schnitzler A, Methner A (2012) Optical coherence tomography in parkinsonian syndromes. PLoS One 7(4):e34891. https://doi.org/10.1371/journal.pone.0034891 CrossRefPubMedPubMedCentral

18.

Archibald NK, Clarke MP, Mosimann UP, Burn DJ (2011) Retinal thickness in Parkinson’s disease. Parkinsonism Relat Disord 17(6):431–436. https://doi.org/10.1016/j.parkreldis.2011.03.004 CrossRefPubMed

19.

Tsironi EE, Dastiridou A, Katsanos A, Dardiotis E, Veliki S, Patramani G, Zacharaki F, Ralli S, Hadjigeorgiou GM (2012) Perimetric and retinal nerve fiber layer findings in patients with Parkinson’s disease. BMC Ophthalmol 12(1):54. https://doi.org/10.1186/1471-2415-12-54 CrossRefPubMedPubMedCentral

20.

Schneider M, Müller HP, Lauda F, Tumani H, Ludolph AC, Kassubek J, Pinkhardt EH (2014) Retinal single-layer analysis in Parkinsonian syndromes: an optical coherence tomography study. J Neural Transm (Vienna) 121(1):41–47. https://doi.org/10.1007/s00702-013-1072-3 CrossRef

21.

Lee JY, Kim JM, Ahn J, Kim HJ, Jeon BS, Kim TW (2014) Retinal nerve fiber layer thickness and visual hallucinations in Parkinson’s disease. Mov Disord 29(1):61–67. https://doi.org/10.1002/mds.25543 CrossRefPubMed

22.

Satue M, Seral M, Otin S, Alarcia R, Herrero R, Bambo MP, Fuertes MI, Pablo LE, Garcia-Martin E (2014) Retinal thinning and correlation with functional disability in patients with Parkinson’s disease. Br J Ophthalmol 98(3):350–355. https://doi.org/10.1136/bjophthalmol-2013-304152 CrossRefPubMed

23.

Roth NM, Saidha S, Zimmermann H, Brandt AU, Isensee J, Benkhellouf-Rutkowska A, Dornauer M, Kühn AA, Müller T, Calabresi PA, Paul F (2014) Photoreceptor layer thinning in idiopathic Parkinson’s disease. Mov Disord 29(9):1163–1170. https://doi.org/10.1002/mds.25896 CrossRefPubMed

24.

Brandt AU, Paul F, Saidha S (2014) Reply to: photoreceptor layer thinning in Parkinsonian syndromes. Mov Disord 29(9):1223–1224. https://doi.org/10.1002/mds.25936 CrossRefPubMed

25.

Muller AK et al (2014) Photoreceptor layer thinning in parkinsonian syndromes. Mov Disord 29(9):1222–1223. https://doi.org/10.1002/mds.25939 CrossRefPubMed

26.

Chorostecki J, Seraji-Bozorgzad N, Shah A, Bao F, Bao G, George E, Gorden V, Caon C, Frohman E, Tariq Bhatti M, Khan O (2015) Characterization of retinal architecture in Parkinson’s disease. J Neurol Sci 355(1–2):44–48. https://doi.org/10.1016/j.jns.2015.05.007 CrossRefPubMed

27.

Spund B, Ding Y, Liu T, Selesnick I, Glazman S, Shrier EM, Bodis-Wollner I (2013) Remodeling of the fovea in Parkinson disease. J Neural Transm (Vienna) 120(5):745–753. https://doi.org/10.1007/s00702-012-0909-5 CrossRef

28.

Bodis-Wollner I (2013) Foveal vision is impaired in Parkinson’s disease. Parkinsonism Relat Disord 19(1):1–14. https://doi.org/10.1016/j.parkreldis.2012.07.012 CrossRefPubMed

29.

Moschos MM, Tagaris G, Markopoulos I, Margetis I, Tsapakis S, Kanakis M, Koutsandrea C (2011) Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur J Ophthalmol 21(1):24–29. https://doi.org/10.5301/EJO.2010.1318 CrossRefPubMed

30.

Palmowski-Wolfe AM, Perez MT, Behnke S, Fuss G, Martziniak M, Ruprecht KW (2006) Influence of dopamine deficiency in early Parkinson’s disease on the slow stimulation multifocal-ERG. Doc Ophthalmol 112(3):209–215. https://doi.org/10.1007/s10633-006-0008-8 CrossRefPubMed

31.

Saidha S, Syc SB, Ibrahim MA, Eckstein C, Warner CV, Farrell SK, Oakley JD, Durbin MK, Meyer SA, Balcer LJ, Frohman EM, Rosenzweig JM, Newsome SD, Ratchford JN, Nguyen QD, Calabresi PA (2011) Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain 134(Pt 2):518–533. https://doi.org/10.1093/brain/awq346 CrossRefPubMed

32.

Papakostopoulos D, Fotiou F, Dean Hart JC, Banerji NK (1989) The electroretinogram in multiple sclerosis and demyelinating optic neuritis. Electroencephalogr Clin Neurophysiol 74(1):1–10. https://doi.org/10.1016/0168-5597(89)90045-2 CrossRefPubMed

33.

Zucco G, Zeni MT, Perrone A, Piccolo I (2001) Olfactory sensitivity in early-stage Parkinson patients affected by more marked unilateral disorder. Percept Mot Skills 92(3 Pt 1):894–898. https://doi.org/10.2466/pms.2001.92.3.894 CrossRefPubMed

Title: Correlations among multifocal electroretinography and optical coherence tomography findings in patients with Parkinson’s disease
Authors: Metin Unlu
Duygu Gulmez Sevim
Murat Gultekin
Cagatay Karaca
Publication date: 01-03-2018
Publisher: Springer Milan
Published in: Neurological Sciences / Issue 3/2018
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-018-3244-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Correlations among multifocal electroretinography and optical coherence tomography findings in patients with Parkinson’s disease

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2018

Comparison of odor identification among amnestic and non-amnestic mild cognitive impairment, subjective cognitive decline, and early Alzheimer’s dementia

Prevalence and clinical characteristics of headache in juvenile myoclonic epilepsy: experience from a tertiary epilepsy center

Mobilization of endothelial progenitor cell in patients with acute ischemic stroke

Successful IVIG treatment without discontinuation of TNF-α blocker in Guillain-Barre syndrome induced by adalimumab in patient with Crohn’s disease

The organisation of the acute ischemic stroke management: key notes of the Italian Neurological Society and of the Italian Stroke Organization

Gender effect on well-being of the oldest old: a survey of nonagenarians living in Tuscany: the Mugello study